|

India Rejects Obvious Patents

Byoliveridley

Would have been my headline. Apparently, the New York Times byline writer was more concerned about a multi billion dollar company losing a small amount of money than the fact that a different ruling in this case would have made life saving drugs unaffordable for millions of people. When did American newspapers become shills for the elite?

Setback for Novartis in India Over Drug Patent – New York Times

Indian companies will be free to continue making less expensive generic drugs, much of which flow to the developing world, after a court rejected a challenge to the patent law on Monday.

Aid organizations declared the ruling a victory for the “rights of patients over patents,” but the Swiss drug company Novartis, which filed the case, warned that the ruling would discourage investments in innovation and would undermine drug companies’ efforts to improve their products.

At issue is the degree of innovation required for a drug to be regarded as truly “new”, where there is a significant enough chance for failure that the company would never develop it unless afforded monopoly rights for 10 years. A very well known tactic by drug companies is to make a slightly different formulation of an existing drug, say an extended release form of a drug which takes a little longer to dissolve, and hence is available to the body at a different time. Under US patent law, this qualifies for full patent protection on the extended release form. By now, the science of making an extended release tablet is well known, it’s just a question of formulating the drug with a different set of inactive ingredients that take longer to dissolve, or sometimes, through a differently engineered tablet. The chemistry of this change is predictable, published and not really innovative. Why should these small changes have patent protection?

Bonus Note: Madras is my home city, so I’m glad it was decided there!

Technorati Tags: , ,

Similar Posts

  • | |

    Green Building in India: NOT

    Byoliveridley

    There is a buzz about green buildings. But the question is: what does one mean by building green? And how does one design policies to make the green homes of our dreams?Green is not about first building structures using lots of material and energy, and then fixing them so that they become a little more efficient. Building green is about optimizing on the local ecology, using local material as far as possible and, most importantly, building to cut the power, water and material requirements.

    via Green buildings: how to redesign | Centre for Science and Environment.

    Sunita Narain makes some excellent points about building in India, and how western architecture influenced glass facades, closed buildings, etc. make little sense in India, and how traditional building concepts, optimised for local conditions would make more sense.

    Two points:

    1. Traditional buildings are not necessarily optimised for density. To fit a lot of people in a little space, you need to build up. No, not 100s of stories, but fives and tens? It would be interesting to figure out that contradiction. But I’m no architect and I don’t know the answer
    2. The glass facade concrete skyscraper jungle look is associated with aspirational prosperity, ask any affluent Indian what they like about Hong Kong, or New York, or Singapore, and the shiny buildings will figure pretty high on the list after cleanliness and shopping. This is the kind of building associated with modernity and “class”. Making a sealed glass and concrete hell hole work in regions of high heat and humidity without large amounts of energy use for air conditioning is difficult.

    It appears, though, that at least some people are thinking about this, as this book, helpfully titled Tropical Sustainable Architecture, would attest to.

    BTW,
    Sunita Narain’s editorials for the Down to Earth magazine are always thoughtful, and required reading for anyone interested in India’s development and environmental issues.

  • | |

    Bhutan to pay for others climate sins

    Byoliveridley

    Bhutan is a small country nestled in the Himalayas, breathtakingly beautiful and “quaint”. Unfortunately, it’s about to be hit by a truck!

    Reuters AlertNet – FEATURE-Bhutan to pay for others climate sins

    The retreat of Bhutan’s glaciers presents an even more formidable and fundamental challenge to a nation of around 600,000 people, nearly 80 percent of whom live by farming.

    Bhutan’s rivers sustain not only the country’s farmers, but also the country’s main industry and export earner — hydro-electric power, mostly sold to neighbouring India.

    For a few years, Bhutan’s farmers and its hydro power plants might have more summer melt water than they can use. One day, though, the glaciers may be gone, and the “white gold” upon which the economy depends may dry up.

    The threat led the government’s National Environment Commission to a stark conclusion.

    “Not only human lives and livelihoods are at risk, but the very backbone of the nation’s economy is at the mercy of climate change hazards,” it wrote in a recent report.

    Scientists admit they have little solid data on how Bhutan’s climate is already changing, but say weather patterns are becoming increasingly unpredictable.

    Well, as I keep saying, Americans and Europeans will be incovenienced by global climate change, Asians and Africans will die. I don’t have an answer, though, which is depressing on this gray and cloudy Friday morning…

  • FDA to add warnings on Anemia Drugs

    Byoliveridley

    Oncologists are being bribed to over-prescribe these drugs, which seem to cause more harm than good when over-prescribed. The FDA is going to add a “warning” label. Let’s see what it does.

    FDA panel urges curbs on 2 anemia drugs – The Boston Globe

    Best-selling anemia drugs from Amgen Inc. and Johnson & Johnson should have their use restricted because of dangerous side effects, a US advisory panel said. Amgen shares fell the most in five years.

    The panel of expert advisers to the Food and Drug Administration voted 15-2 in favor of new prescribing restrictions and 17-0 for new clinical trials during a meeting yesterday in Silver Spring, Md.

    Shares of Amgen fell $5.77, or 9.1 percent, to $57.33 in Nasdaq Stock Market composite trading. J&J shares fell $1.61, or 2.5 percent, to $62.50 on the New York Stock Exchange.

    The drugs raised the risk of heart attacks, strokes, and death when used at high doses, studies released in the last six months showed. An FDA warning in March prompted the US health program for the elderly and disabled to stop paying for treatments in certain patients, and doctors cut back on use. The products accounted for $6.6 billion, or 47 percent, of Amgen revenue in 2006.

    “Many of us are concerned on the committee and have a lot of questions,” said Gail Eckhardt, an oncologist at the University of Colorado in Aurora, and the advisory panel’s chairwoman.

    The questions concerned the design of trials, why regulators have limited access to results from company studies, and why the drugs have been marketed for improving quality of life if there isn’t sufficient evidence for the claim, Eckhardt said.

    The FDA usually follows the recommendations of its advisory panels, although it isn’t required to do so.

  • |

    Brazil proposes G5 summit

    Byoliveridley

    interesting news that India, China, Mexico, Brazil and South Africa decide that they no longer need to be invited to the (not so) G(r)8 meeting to talk to each other. This is a welcome development in many ways, may they keep talking.

    The Hindu : Front Page : Brazil proposes G5 summit

    Though largely overshadowed by the brief “pull aside” Prime Minister Manmohan Singh had with U.S. President George W. Bush, the most significant aspect of last week’s G8 meetings was the new dialectic that emerged among the five countries which were invited to Germany as “outreach” partners.

    At a meeting of the five — Brazil, China, India, Mexico and South Africa — Brazilian President Luis Inacio Lula da Silva took the lead in proposing that the group consider getting together again at a forum other than that of the G8 so that its own meetings are no longer incidental to the meetings and agenda of the eight most industrialised countries.

    The proposal was welcomed by the other leaders, say Indian officials familiar with the June 7 deliberations of the “outreach,” or O-5, in Berlin. China’s President Hu Jintao noted that the five countries together accounted for 42 per cent of the world’s population and Dr. Singh quoted an old statement of Jawaharlal Nehru that developing countries were partners and not petitioners before the chanceries of the world.

  • |

    Fundamentalism alive and well in the US

    Byoliveridley

    As a card carrying agnostic, my Hindu pride is not shattered, but these people need to get a life. Read the whole article, there’s more about “false gods” and such.

    Of course, some Hindus happily accept Jesus as another god, or avatar of some kind, so, fret not O denizens of Saved America, your god has already been assimilated into the Hindu pantheon.

    Christian activists disrupt Hindu prayer in US Senate-The United States-World-The Times of India

    Christian activists briefly disrupted a Hindu invocation in the US Senate on Thursday, marring a historic first for the chamber and showing that fundamentalism is present and shouting in the US too.

    Invited by the Senate to offer Hindu prayers in place of the usual Christian invocation, Rajan Zed, a Hindu priest from Reno, Nevada, had just stepped up to the podium for the landmark occasion when three protesters, said to belong to the Christian Right anti-abortion group Operation Save America, interrupted by loudly asking for God’s forgiveness for allowing the ”false prayer” of a Hindu in the Senate chamber.

    “Lord Jesus, forgive us father for allowing a prayer of the wicked, which is an abomination in your sight,” the first protester shouted. “This is an abomination. We shall have no other gods before you.”